KNRLF yields 3703.70% · MRK yields 2.76%● Live data
📍 KNRLF pulled ahead of the other in Year 1
Combined, KNRLF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KNRLF + MRK for your $10,000?
Kontrol Technologies Corp., through its subsidiaries, provides energy management, emission compliance, and air quality solutions and services in Canada and the United States. It offers turn-key solutions to building owners and asset managers in the commercial, industrial, and multi-residential sector, which include software to analyze the management of heating, cooling, and ventilation (HVAC) systems; design and engineering of improvements and/or retrofits; and ongoing mission critical services. The company also provides integrated installations of heating, ventilation, cooling, and business automation systems to its customers; greenhouse gas verification, installation of critical emission management systems, and stack testing for environmental emissions; and Kontrol BioCloud, a solution to provide real-time viral detection technology. In addition, it offers energy auditing, monitoring and verification, energy project assessment, mechanical, electrical, and renewable design, as well as LEED facilitation services; monitoring, operation, and service of essential heating, cooling, ventilation, and utility systems; stack emission testing, continuous emission testing, power generation, due diligence, odour assessment and analytics, compliance, and other engineering services; and monitoring solutions, services, and product sales. The company is headquartered in Vaughan, Canada.
Full KNRLF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.